Lifastuzumab vedotin
Lifastuzumab vedotin

Western blot analysis of beta actin in COS7, Jurkat, C6 and 3T3 lysates using beta actin antibody (1:5000 diluted).

Lifastuzumab vedotin
Cat：
GS90030
Type：
Antibody
Immunogen：
NaPi2b
Reactivity：
Human
Applications：
Reference Antibody
Price：
＄
Lifastuzumab-vedotin-GS90030
Data Sheet
MSDS
  • Product details
Product Name
Lifastuzumab vedotin
Cat
GS90030
Heavy chain
EVQLVESGGGLVQPGGSLRLSCAASGFSFSDFAMSWVRQAPGKGLEWVATIGRVAFHTYYPDSMKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHRGFDVGHFDFWGQGTLVTVSS
Light chain
DIQMTQSPSSLSASVGDRVTITCRSSETLVHSSGNTYLEWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFQGSFNPLTFGQGTKVEIK
Isotype
IgG
Host
Humanised
Purity
>95% by SDS-PAGE
Endotoxin
<1.0 EU/μg as determined by LAL method
Immunogen
NaPi2b
Reactivity
Human
Applications
Reference Antibody
Conjugated
MMAE
Buffer
Preservative:0.01M PBS, PH 7.4
Storage
store at -20°C or -80°C. Avoid repeated freeze.
Type
Antibody
Purposes
For research use only
previous:Lorvotuzumab-MMAEnext:Sirtratumab vedotin

Related products